Efficacy and safety of dose-escalated alectinib in patients with metastatic ALK-positive NSCLC and CNS relapse on standard dose alectinib

被引：0
|
作者：
Cheung, Justin Matthew
Kang, Jiyoon
Yeap, Beow Y.
Peterson, Jenn
Do, Andrew
Digumarthy, Subba R.
Gainor, Justin F.
Lin, Jessica Jiyeong
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21079
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Dose-Escalated Alectinib in Patients with Metastatic ALK-positive NSCLC and CNS Relapse on Standard Dose Alectinib
    Cheung, Justin M.
    Kang, Jiyoon
    Yeap, Beow Y.
    Peterson, Jennifer L.
    Do, Andrew
    Gainor, Justin F.
    Digumarthy, Subba R.
    Lin, Jessica J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E31 - E31
  • [2] Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib
    Cheung, Justin M.
    Kang, Jiyoon
    Yeap, Beow Y.
    Peterson, Jennifer L.
    Do, Andrew
    Gainor, Justin F.
    Digumarthy, Subba R.
    Lin, Jessica J.
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (03):
  • [3] Alectinib shows CNS efficacy in ALK-positive NSCLC
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2018, 19 (10): : E520 - E520
  • [4] Efficacy of Alectinib in Patients with ALK-Positive NSCLC and Symptomatic or Large CNS Metastases
    Lin, Jessica J.
    Jiang, Ginger Y.
    Joshipura, Nencyben
    Ackil, Jennifer
    Digumarthy, Subba R.
    Rincon, Sandra P.
    Yeap, Beow Y.
    Gainor, Justin F.
    Shaw, Alice T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) : 683 - 690
  • [5] Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study
    Zihua Zou
    Puyuan Xing
    Xuezhi Hao
    Yan Wang
    Xia Song
    Li Shan
    Cuiying Zhang
    Ziling Liu
    Kewei Ma
    Guilan Dong
    Junling Li
    BMC Medicine, 20
  • [6] Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases: A multicenter retrospective study
    Zou, Z.
    Xing, P.
    Hao, X.
    Wang, Y.
    Shan, L.
    Zhang, C.
    Song, X.
    Ma, K.
    Liu, Z.
    Dong, G.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S781 - S782
  • [7] Alectinib: A Review in Advanced, ALK-Positive NSCLC
    Paik, Julia
    Dhillon, Sohita
    DRUGS, 2018, 78 (12) : 1247 - 1257
  • [8] Alectinib: A Review in Advanced, ALK-Positive NSCLC
    Julia Paik
    Sohita Dhillon
    Drugs, 2018, 78 : 1247 - 1257
  • [9] Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases-a multicenter retrospective study
    Zou, Zihua
    Xing, Puyuan
    Hao, Xuezhi
    Wang, Yan
    Song, Xia
    Shan, Li
    Zhang, Cuiying
    Liu, Ziling
    Ma, Kewei
    Dong, Guilan
    Li, Junling
    BMC MEDICINE, 2022, 20 (01)
  • [10] Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC
    Lin, Jessica J.
    Zhu, Viola W.
    Schoenfeld, Adam J.
    Yeap, Beow Y.
    Saxena, Ashish
    Ferris, Lorin A.
    Dagogo-Jack, Ibiayi
    Farago, Anna F.
    Taber, Angela
    Traynor, Anne
    Menon, Smitha
    Gainor, Justin F.
    Lennerz, Jochen K.
    Plodkowski, Andrew J.
    Digumarthy, Subba R.
    Ignatius, Sai-Hong
    Shaw, Alice T.
    Riely, Gregory J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : 1530 - 1538
12345